Surgery Partners, Inc. (SGRY) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $14.29 (+1.82%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 4, 2026 | Brian Tanquilut | Jefferies | $16.25 | +13.8% |
| Mar 4, 2026 | Ben Hendrix | RBC Capital | $20.00 | +40.0% |
| Nov 13, 2024 | Brian Tanquilut | Jefferies | $40.00 | +180.0% |
| Nov 13, 2024 | Andrew Mok | Barclays | $31.00 | +117.0% |
| Oct 14, 2024 | AJ Rice | UBS | $38.00 | +166.0% |
| Jun 28, 2024 | Tao Qiu | Macquarie | $31.00 | +117.0% |
Top Analysts Covering SGRY
SGRY vs Sector & Market
| Metric | SGRY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.25 | 2.24 | 2.41 |
| Analyst Count | 12 | 8 | 18 |
| Target Upside | +30.2% | +1150.2% | +14.9% |
| P/E Ratio | -23.43 | 6.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.39B | $3.41B | $3.45B | 8 |
| 2027-03-31 | $823M | $840M | $862M | 4 |
| 2027-06-30 | $878M | $896M | $919M | 3 |
| 2027-09-30 | $884M | $902M | $925M | 3 |
| 2027-12-31 | $962M | $981M | $1.01B | 3 |
| 2028-03-31 | $841M | $858M | $880M | 2 |
| 2028-06-30 | $900M | $918M | $942M | 5 |
| 2028-09-30 | $891M | $909M | $932M | 4 |
| 2028-12-31 | $984M | $1.00B | $1.03B | 4 |
| 2029-12-31 | $4.45B | $4.52B | $4.66B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.25 | $0.39 | $1.34 | 6 |
| 2027-03-31 | $-0.05 | $-0.05 | $-0.05 | 1 |
| 2027-06-30 | $0.13 | $0.13 | $0.13 | 1 |
| 2027-09-30 | $0.15 | $0.16 | $0.16 | 1 |
| 2027-12-31 | $0.32 | $0.33 | $0.34 | 1 |
| 2028-03-31 | $-0.03 | $-0.03 | $-0.03 | 2 |
| 2028-06-30 | $0.17 | $0.17 | $0.18 | 2 |
| 2028-09-30 | $0.16 | $0.16 | $0.17 | 2 |
| 2028-12-31 | $0.35 | $0.36 | $0.37 | 2 |
| 2029-12-31 | $0.83 | $0.85 | $0.88 | 1 |
Frequently Asked Questions
What is the analyst consensus for SGRY?
The consensus among 12 analysts covering Surgery Partners, Inc. (SGRY) is Buy with an average price target of $18.85.
What is the highest price target for SGRY?
The highest price target for SGRY is $40.00, set by Brian Tanquilut at Jefferies on 2024-11-13.
What is the lowest price target for SGRY?
The lowest price target for SGRY is $16.25, set by Brian Tanquilut at Jefferies on 2026-03-04.
How many analysts cover SGRY?
12 analysts have issued ratings for Surgery Partners, Inc. in the past 12 months.
Is SGRY a buy or sell right now?
Based on 12 analyst ratings, SGRY has a consensus rating of Buy (2.25/5) with a +30.2% upside to the consensus target of $18.85.
What are the earnings estimates for SGRY?
Analysts estimate SGRY will report EPS of $0.39 for the period ending 2026-12-31, with revenue estimated at $3.41B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.